PlainPill

Buspirone

Also known as Buspar

The short answer. People are split on Buspirone — 53% of 34 say it helped. It is most often used for anxiety: 76% of 33 reports say that improved. It is well studied — 68 meta-analyses on PubMed. The most common complaint is dizziness.

What users report
53%helped34 reports · medium confidence
18 helped6 mixed10 didn't help

From 66 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
68
meta-analyses
240
RCTs
2,993
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Buspirone does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 68 meta-analyses on PubMed ↗ · 240 randomized trials ↗

Lancet · 2019 · Meta-analysis / systematic review
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis

Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.

PubMed 30712879 ↗
BMJ Clin Evid · 2008 · Meta-analysis / systematic review
Panic disorder

Conclusion: In this systematic review we present information relating to the effectiveness and safety of the following interventions: applied relaxation, benzodiazepines, breathing retraining, brief dynamic psychotherapy, buspirone, client-centred therapy, cognitive behavioural therapy (CBT) (alone or plus drug treatments), cognitive restructuring, couple therapy, exposure (external or interoceptive), insight-orientated therapy, monoamine oxidase inhibitors (MAOIs), psychoeducation, selective serotonin reuptake inhibitors (SSRIs), self-help, and tricyclic antidepressants (imipramine).

PubMed 19445787 ↗
J Psychopharmacol · 2025 · Meta-analysis / systematic review
Navigating agitation in neurodevelopmental disorders: A comparative study of pharmacotherapies via network meta-analysis in children and adults with autism spectrum disorder or intellectual disabilities

Conclusion: This study underscores the efficacy and tolerability of several pharmacotherapies in managing agitation among children and adults with ASD or ID. Our findings provide robust evidence that specific treatments, such as arbaclofen, risperidone plus buspirone and omega-3 fatty acids, are both effective and well-tolerated, offering valuable therapeutic options for clinicians. The study emphasizes the need for ongoing research to ensure that treatment strategies remain aligned with the evolving clinical landscape, ultimately improving patient outcomes in this challenging population.

PubMed 39690490 ↗
Registered clinical trials

72 human trials on ClinicalTrials.gov test Buspirone — 48 completed, 7 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

The current US prescription label has no boxed warning.

Full label on DailyMed (NIH) ↗

FDA recalls

11 recalls of products named for Buspirone. Most recent:

  • 2026-05-13 · Class III: Subpotent drug record ↗
  • 2023-11-29 · Class III: Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots record ↗
  • 2023-05-03 · Class II: CGMP Deviations record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

10,970 adverse-event reports mention Buspirone. Most often reported:

  • Fatigue · 800
  • Nausea · 797
  • Headache · 731
  • Drug ineffective · 671
  • Anxiety · 668
  • Dyspnoea · 584

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Buspirone E — an unlikely cause of liver injury. LiverTox entry ↗

US government research funding (NIH)

NIH has funded 15 research projects with Buspirone in the title, $3,445,737 in total (1985–2014). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Buspirone ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

dizziness ×4headache ×2heart palpitations ×1panic attacks ×1fainting ×1nausea ×1difficulty reaching ×1blood pressure ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I’ve been taking the buspar these last couple days and it seems to handle my level of anxiety quite well.”
HelpedRead the discussion ↗
“came back with Buspirone which is not an SSRI. It has its own issues, but I could sleep.”
MixedRead the discussion ↗
“I've been on 5 mg twice a day for about a year. I can't really notice the effects on anxiety, but when I ran out...my anxiety was through the roof.”
MixedRead the discussion ↗
“The only drugs that has helped at all so far have been Buspar and Remeron, both of which eventually stopped working for me.”
MixedRead the discussion ↗
Read more Buspirone reviews →
Top discussions (5)

Buspirone compared

Other options for anxiety

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate